Literature DB >> 20237902

The role of Crk/Dock180/Rac1 pathway in the malignant behavior of human ovarian cancer cell SKOV3.

Hui Wang1, Hua Linghu, Jin Wang, Ya-ling Che, Ting-xiu Xiang, Wei-xue Tang, Zhen-wei Yao.   

Abstract

Small GTPases, particularly the Rho family, are key regulators of cell motility and migration. Dock180 was well known for the main target of signal adaptor protein Crk and acted as a guanine-nucleotide exchange factor for small GTPase Rac1. In the present study, Dock180 was found to combine primarily with CrkI other than CrkII, and its association with Elmo1 was also demonstrated in ovarian cancer cell SKOV3. To evaluate the role of Dock180 in human ovarian cancer cell, we performed RNAi-mediated knockdown of Dock180 in SKOV3 cells using small interfering RNA expression vector. In Dock180 knockdown cells, we found that Elmo1 expression and Rac1 activity were decreased simultaneously. By contrast, the expressions of both another Crk-combining molecule C3G and Rap1 activity were observed to increase obviously. Accordingly, all Dock180 knockdown cells present with evident change in cell morphology, reduced cell proliferation, and attenuated cell migration. Taken together, these results suggest that signal transfer of Crk/Dock180/Rac1 is implicated in actin cytoskeleton reorganization and thus in the cell proliferation, motility, invasion, and of human ovarian cancer cell line SKOV3.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20237902     DOI: 10.1007/s13277-009-0009-9

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  34 in total

Review 1.  Rho GTPases in cell biology.

Authors:  Sandrine Etienne-Manneville; Alan Hall
Journal:  Nature       Date:  2002-12-12       Impact factor: 49.962

2.  A ras-related gene with transformation suppressor activity.

Authors:  H Kitayama; Y Sugimoto; T Matsuzaki; Y Ikawa; M Noda
Journal:  Cell       Date:  1989-01-13       Impact factor: 41.582

3.  ELMO1 and Dock180, a bipartite Rac1 guanine nucleotide exchange factor, promote human glioma cell invasion.

Authors:  Michael J Jarzynka; Bo Hu; Kwok-Min Hui; Ifat Bar-Joseph; Weisong Gu; Takanori Hirose; Lisa B Haney; Kodi S Ravichandran; Ryo Nishikawa; Shi-Yuan Cheng
Journal:  Cancer Res       Date:  2007-08-01       Impact factor: 12.701

4.  Molecular and immunohistochemical analysis of signaling adaptor protein Crk in human cancers.

Authors:  Hiroshi Nishihara; Shinya Tanaka; Masumi Tsuda; Sumie Oikawa; Masae Maeda; Michio Shimizu; Hiroichi Shinomiya; Akira Tanigami; Hirofumi Sawa; Kazuo Nagashima
Journal:  Cancer Lett       Date:  2002-06-06       Impact factor: 8.679

5.  CED-12/ELMO, a novel member of the CrkII/Dock180/Rac pathway, is required for phagocytosis and cell migration.

Authors:  T L Gumienny; E Brugnera; A C Tosello-Trampont; J M Kinchen; L B Haney; K Nishiwaki; S F Walk; M E Nemergut; I G Macara; R Francis; T Schedl; Y Qin; L Van Aelst; M O Hengartner; K S Ravichandran
Journal:  Cell       Date:  2001-10-05       Impact factor: 41.582

Review 6.  Epithelial-mesenchymal transition in development and cancer: role of phosphatidylinositol 3' kinase/AKT pathways.

Authors:  Lionel Larue; Alfonso Bellacosa
Journal:  Oncogene       Date:  2005-11-14       Impact factor: 9.867

7.  Laminin-10/11 and fibronectin differentially regulate integrin-dependent Rho and Rac activation via p130(Cas)-CrkII-DOCK180 pathway.

Authors:  J Gu; Y Sumida; N Sanzen; K Sekiguchi
Journal:  J Biol Chem       Date:  2001-05-21       Impact factor: 5.157

8.  CrkI adapter protein modulates cell migration and invasion in glioblastoma.

Authors:  Takahisa Takino; Mitsutoshi Nakada; Hisashi Miyamori; Junkoh Yamashita; Kenneth M Yamada; Hiroshi Sato
Journal:  Cancer Res       Date:  2003-05-01       Impact factor: 12.701

9.  C3G, a guanine nucleotide-releasing protein expressed ubiquitously, binds to the Src homology 3 domains of CRK and GRB2/ASH proteins.

Authors:  S Tanaka; T Morishita; Y Hashimoto; S Hattori; S Nakamura; M Shibuya; K Matuoka; T Takenawa; T Kurata; K Nagashima
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-12       Impact factor: 11.205

Review 10.  Dissemination and growth of cancer cells in metastatic sites.

Authors:  Ann F Chambers; Alan C Groom; Ian C MacDonald
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

View more
  17 in total

1.  Identification of germline genomic copy number variation in familial pancreatic cancer.

Authors:  Wigdan Al-Sukhni; Sarah Joe; Anath C Lionel; Nora Zwingerman; George Zogopoulos; Christian R Marshall; Ayelet Borgida; Spring Holter; Aaron Gropper; Sara Moore; Melissa Bondy; Alison P Klein; Gloria M Petersen; Kari G Rabe; Ann G Schwartz; Sapna Syngal; Stephen W Scherer; Steven Gallinger
Journal:  Hum Genet       Date:  2012-06-05       Impact factor: 4.132

2.  The Role of Ect2 Nuclear RhoGEF Activity in Ovarian Cancer Cell Transformation.

Authors:  Lauren P Huff; Molly J Decristo; Dimitri Trembath; Pei Fen Kuan; Margaret Yim; Jinsong Liu; Danielle R Cook; C Ryan Miller; Channing J Der; Adrienne D Cox
Journal:  Genes Cancer       Date:  2013-11

3.  PTTG induces EMT through integrin αVβ3-focal adhesion kinase signaling in lung cancer cells.

Authors:  P P Shah; M Y Fong; S S Kakar
Journal:  Oncogene       Date:  2011-11-14       Impact factor: 9.867

4.  Emerging roles for crk in human cancer.

Authors:  Ganapathy Sriram; Raymond B Birge
Journal:  Genes Cancer       Date:  2010-11

Review 5.  Role of ELMO1 in inflammation and cancer-clinical implications.

Authors:  Stefania Tocci; Stella-Rita Ibeawuchi; Soumita Das; Ibrahim M Sayed
Journal:  Cell Oncol (Dordr)       Date:  2022-06-06       Impact factor: 7.051

6.  The clinical implications of Crk-like adaptor protein expression in papillary thyroid microcarcinoma.

Authors:  Xiangshan Yang; Wenyuan Lv; Ranran Shi; Shaomei Cheng; Jing Zhang; Zhongfa Xu
Journal:  Tumour Biol       Date:  2014-09-04

7.  MCAM is a novel metastasis marker and regulates spreading, apoptosis and invasion of ovarian cancer cells.

Authors:  Zheng Wu; Zhiyong Wu; Jun Li; Xiaomei Yang; Yahui Wang; Yi Yu; Jun Ye; Congjian Xu; Wenxin Qin; Zhigang Zhang
Journal:  Tumour Biol       Date:  2012-05-19

8.  Oncogenic CagA promotes gastric cancer risk via activating ERK signaling pathways: a nested case-control study.

Authors:  Jae Jeong Yang; Lisa Y Cho; Seung Hyun Ma; Kwang-Pil Ko; Aesun Shin; Bo Youl Choi; Dong Soo Han; Kyu Sang Song; Yong Sung Kim; Soung-Hoon Chang; Hai-Rim Shin; Daehee Kang; Keun-Young Yoo; Sue K Park
Journal:  PLoS One       Date:  2011-06-16       Impact factor: 3.240

9.  Pro-survival effect of Dock180 overexpression on rat-derived H9C2 cardiomyocytes.

Authors:  An Yan; Gang Li; Xu Zhang; Bingbao Zhu; Hua Linghu
Journal:  Med Sci Monit Basic Res       Date:  2013-01-14

10.  Domain organization differences explain Bcr-Abl's preference for CrkL over CrkII.

Authors:  Wojciech Jankowski; Tamjeed Saleh; Ming-Tao Pai; Ganapathy Sriram; Raymond B Birge; Charalampos G Kalodimos
Journal:  Nat Chem Biol       Date:  2012-05-13       Impact factor: 15.040

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.